Endo, Inc. Partners with MC2 Therapeutics to Bring Wynzora® Cream to Canadian Market
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has reached a definitive agreement with MC2 Therapeutics to commercialize Wynzora® Cream in Canada through its subsidiary, Paladin Pharma Inc. This strategic move …
Endo, Inc. Partners with MC2 Therapeutics to Bring Wynzora® Cream to Canadian Market Read More